Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Dated: 23/03/22
Out of: USA, Germany
300,000 CS + warrant @ $1.26 = $378,000.00 CAN
Warrant: $1.26 Expires 2027-03-23
Koo